JULIE BELNAP: Open Payments
NPI 1790384873 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 44 payments from 15 companies in 2025. Trend: 2023 $73 · 2024 $337 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $204 |
| AstraZeneca Pharmaceuticals LP | 2 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $60 |
| PFIZER INC. | 4 | $60 |
| Novo Nordisk Inc | 2 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| ABIOMED | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: REXULTI, AIRSUPRA, QULIPTA, UBRELVY, NURTEC ODT, VRAYLAR, Veozah, CREON.
Industry payments across KS — which companies pay providers there.
